Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
A narrative review synthesizing recent advances in CRISPR delivery strategies across research and clinical contexts, offering state-of-the-art overview rather than novel empirical evidence or recommendations.
A prospective multicenter clinical evaluation demonstrating 100% sensitivity for S. aureus detection in 350 patients with suspected bacteremia, but limited by small MRSA case numbers (n=8) and lack of specificity data, requiring confirmation in larger MRSA-enriched cohorts before clinical implementation.
A narrative review of preclinical literature synthesizing nanocarrier design and CRISPR delivery mechanisms, raising research directions rather than reporting original empirical evidence or clinical outcomes.
This is a narrative review article that synthesizes existing knowledge about genetic engineering applications in medicinal plants; it presents conceptual frameworks and potential approaches rather than original empirical evidence or a clinical trial result.
This is a narrative review discussing CRISPR-Cas potential in oncology without reporting empirical data, clinical outcomes, or trial results; it presents conceptual possibilities and technical developments rather than evidence of efficacy.
This is a narrative review synthesizing mechanistic concepts and emerging data on CCR5-targeted approaches; it raises questions about therapeutic potential rather than reporting a definitive trial result or meta-analysis.
This is a narrative review surveying AI-guided drug discovery approaches in ophthalmology with mostly preclinical findings; it raises questions about translational potential rather than reporting clinical evidence or definitive efficacy.
A comprehensive narrative review synthesizing mechanisms, delivery strategies, and clinical applications of multiple RNA therapeutic modalities, not a primary empirical study.